anti-HIV AMPs Molecule 3

General Information


DRACP ID  DRACP00985

Peptide Name   anti-HIV AMPs Molecule 3

Sequence  RWKLFKKIEKVGRNVRDGLIKAGPAIAVIGQAKSLGK

Sequence Length  37

UniProt ID  Not available

PubChem CID  Not available

Origin  Bombyx mori

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HepG2 Hepatoblastoma Blastoma 20% Killing=100 µg/ml MTT assay 48h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  HEK293T: 40% Killing=100µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00985

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C185H318N56O45

Absent amino acids  CHMTY

Common amino acids  K

Mass  468924

Pl  11.86

Basic residues  10

Acidic residues  2

Hydrophobic residues  16

Net charge  8

Boman Index  -5091

Hydrophobicity  -21.89

Aliphatic Index  108.11

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  152.78

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 32322274

Title  Antibacterial Activity of Rationally Designed Antimicrobial Peptides

Doi 10.1155/2020/2131535

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.